Cognition Disorders - Metabolism
Research News and Information

Sunday, November 22, 2009

Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism.

Nov 2009 BACKGROUND AND PURPOSE: Most studies on mild cognitive impairment (MCI) have been focused on amnestic MCI (aMCI) that is the preclinical stage of Alzheimer's disease (AD). In contrast, only a few studies have involved patients in the preclinical ... Read more...

Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.

12 Oct 2009 Upon activation by calcineurin, the nuclear factor of activated T-cells (NFAT) translocates to the nucleus and guides the transcription of numerous molecules involved in inflammation and Ca(2+) dysregulation, both of which are prominent features of ... Read more...

Relationships between biomarkers in aging and dementia.

11 Oct 2009 BACKGROUND: PET imaging using [(18)F]fluorodeoxyglucose (FDG) and [(11)C]Pittsburgh compound B (PIB) have been proposed as biomarkers of Alzheimer disease (AD), as have CSF measures of the 42 amino acid beta-amyloid protein (Abeta(1-42)) and total ... Read more...

Latest indexed articles for 'Cognition Disorders - Metabolism'

These are the very latest articles for this heading:

• Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism. Nov 2009
• Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. 12 Oct 2009
• Relationships between biomarkers in aging and dementia. 11 Oct 2009
• Addressing Alzheimer's disease tangles: from NAP to AL-108. 29 Sep 2009
• The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380. 30 Aug 2009
• Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice. 19 Aug 2009
• 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment. 16 Aug 2009
• Cognitive reserve in relation to abeta42 in patients converting from MCI to dementia - a follow-up report. 11 Aug 2009
• Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice. 3 Aug 2009
• Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum. 30 Jul 2009
• Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. 30 Jul 2009
• Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. 30 Jul 2009
• Serum biomarkers of vascular cognitive impairment evaluated by bead-based proteomic technology. 21 Jul 2009
• From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up. 29 Jun 2009
• Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. 29 Jun 2009
• Clinical applications of PET amyloid imaging: an update. 29 Jun 2009
• Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders. 19 Jun 2009
• Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. 15 Jun 2009
• Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. 8 Jun 2009
• Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. 7 Jun 2009

See a longer list of these articles.

Technical information about 'Cognition Disorders'

Definition: Disturbances in the mental process related to thinking, reasoning, and judgment.

Descriptor UI: D003072

Alternative terms: Cognition Disorders; Disorder, Cognition; Disorders, Cognition; Overinclusion;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;

Tree Number: F03.087.250;

History Note: 69